Publication Search

Leprosy is a chronic infectious disease caused by Mycobacterium leprae, an obligate intracellular bacterium that affects the skin, peripheral nerves, upper respiratory mucosa, and eyes. Type 2 diabetes mellitus (T2DM) is a comorbidity that can worsen the course of leprosy. The female patient, Mrs. D, aged 55 years came to the emergency room of Cut Meutia Hospital with the main complaint of red bumps accompanied by pain on the face, hands, chest, and back since 3 days ago and additional complaints such as fever, joint pain, and numbness and loss of feeling in the legs, weakness, frequent thirst, and frequent urination. Dermatologic status is obtained in the facial region in the form of erythema nodules with firm boundaries with numular size, multiple. Laboratory examination showed anemia and leukocytosis. The therapy given was MDT MB package, ferrous sulfate 1x325 mg and PRC transfusion 3 kolf. Complaints arose acutely after the patient resumed taking MDT (multidrug therapy) leprosy drugs which had previously been stopped for more than 3 months. Based on the time of onset of symptoms, history of leprosy treatment, and the manifestation of systemic inflammatory lesions with signs of neurotropism, it can be suspected that the patient is experiencing a type 2 leprosy reaction or Erythema Nodosum Leprosum (ENL).

Masalah kesehatan internasional adalah hipertensi, penyebab utama gagal ginjal, stroke, dan penyakit jantung. Diperkirakan 34,1% orang di Indonesia menderita hipertensi, dan sebagian besar dari mereka tidak mendapatkan pengobatan. Meskipun Puskesmas Welahan 1 menangani hipertensi, pasien sering mengalami kesulitan mengontrol tekanan darah mereka karena berbagai macam obat yang tersedia. Tujuan dari penelitian ini adalah untuk mengetahui seberapa efektif terapi monoterapi dan kombinasi untuk mencapai target tekanan darah pasien hipertensi di Puskesmas Welahan 1 dan bagaimana berbagai obat mempengaruhi kontrol tekanan darah. Data dari 60 pasien hipertensi yang memenuhi kriteria inklusi dianalisis selama tiga bulan menggunakan pendekatan cross-sectional. Digunakan statistik inferensial dan deskriptif, seperti uji chi-square. Tidak ada korelasi signifikan antara kontrol tekanan darah sistolik dan diastolik dan jenis terapi obat (p > 0,05). Namun, pasien yang menerima amlodipine atau amlodipine + captopril lebih mampu mengontrol tekanan darah mereka, dengan rasio kemungkinan 0,857 untuk tekanan sistolik dan 6,429 untuk tekanan diastolik, masing-masing.  Hasilnya menunjukkan bahwa terapi kombinasi mungkin membantu mengontrol tekanan darah diastolik, meskipun jenis obat tidak mempengaruhi tekanan darah secara langsung

Background: One of the non-communicable diseases (NCDs) that has received a lot of attention is Diabetes Mellitus. Diabetes management is divided into two ways. The first way is with non-drug therapy (non-pharmacological) and second with drug therapy. Drug therapy in the form of oral hypoglycemic drugs or insulin. Non-pharmacological methods with food planning and physical exercise. The type of light physical exercise recommended for patients with type II diabetes mellitus is walking and brisk walking. Objective: To determine the effect of brisk walking to reduce blood glucose levels in patients with type 2 diabetes mellitus. Methods: This review uses the literature review method. Searches were conducted in PubMed, Garuda, and Google Scholar. The search strategy used keywords with "brisk walking", "physical exercise", "glycemic control", "diabetes mellitus, type II",. Results: Seven articles were reviewed in this literature review. Six articles discussed brisk walking, one article discussed the difference in glycemic control in low - high intensity interval training with endurance training. The overall results of this review show that doing physical activity brisk walking has an effect in reducing blood glucose levels, reducing blood glucose levels by 49.75 mg/dL. Physical activity sessions can be done for 3 - 7 sessions per week with a duration of 15 - 60 minutes. Conclusion: The effect of brisk walking is proven to reduce blood glucose levels in patients with type 2 diabetes mellitus.

Control efforts with the DOTS (Directly Observed Treatment Short-course) strategy have been implemented. The side effects of this drug will continue as long as the sufferer takes it, furthermore anti-TB drugs (OAT) will change the metabolism in the sufferer's body. Chronic effects that arise from OAT treatment include increased levels of uric acid, glucose and hemoglobin in the blood. From the results of a preliminary study, data collection was carried out on the number of pulmonary TB sufferers in Kupang City in 2021, amounting to 385. Of this number, 72 cases were found at the Oesapa Community Health Center who were smear positive for pulmonary TB and had recovered and were still undergoing treatment. For this reason, it is necessary to carry out research to determine blood glucose, uric acid and hemoglobin levels in pulmonary tuberculosis (TB) patients who take OAT (anti-TB drugs) before taking, after taking 2 months and 6 months of treatment. This research method is descriptive and statistical. Statistical analysis using One Way Anova and Linear Regression tests was used to determine the effect of length of treatment on blood profiles in pulmonary tuberculosis sufferers. TB sufferers with anti-tuberculosis drug therapy at the Oesapa Community Health Center based on the age of the patient, there were 11 sufferers aged <30 years (55%), 9 sufferers aged >30 years (45%). Based on gender, 13 sufferers were female (65%), 7 sufferers were male (35%). Hemoglobin levels checked before treatment showed a mean of 13.015 g/dL, during 2 months of treatment 13.185 g/dL, and after 6 months of treatment the mean was 11.94 g/dL. The current blood sugar levels from table 1.3 above which were checked before treatment showed an average of 137.7 g/dL, during 2 months of treatment 145.15 g/dL, and after 6 months of treatment the average was 144.15 g/dL. Uric acid levels were based on the respondent's length of treatment with an average uric acid level before treatment of 6.16 mg/dL, 2 months of treatment 5.92 mg/dL and 6 months of treatment 6.43 mg/dL. Hemoglobin levels, instant blood sugar and uric acid before, 2 months and 6 months of treatment showed a p value <0.05, meaning the data was not normally distributed. The results of the analysis using the Friedman anova test showed a p value (0.137) > 0.05. This means there is no difference in uric acid measurement values ??before, 2 months and 6 months of treatment. The results of the analysis using the Friedman anova test showed a p value (0.142) > 0.05. This means that there is no difference in blood sugar measurement values ??before, 2 months and 6 months of treatment. The results of the analysis using the Friedman anova test showed a p value (0.378) > 0.05. This means there is no difference in Hb measurement values ??before, 2 months and 6 months of treatment